-
Scientist Who Helped Develop Pfizer-BioNTech Covid Vaccine Agrees Third Shot Is Needed as Immunity Wanes
The chief medical officer of BioNTech told CNBC that people will likely need a third shot of its two-dose Covid-19 vaccine as immunity against the virus wanes.
-
FDA Finds Poor Conditions at Baltimore Plant That Ruined Millions of Doses of J&J Covid Vaccine
The FDA said a Baltimore plant that ruined millions of Johnson & Johnson Covid-19 vaccine doses was unsanitary and unsuitable to manufacture the shots.
-
Johnson & Johnson Reports $100 Million in Quarterly Sales From Covid Vaccine
J&J’s financial results come as the company’s Covid-19 vaccine has been put on pause in the United States.
-
U.S. Covid Vaccination Obstacle Shifts Towards Lack of Demand From Scarce Supply, Warns Doctor
Dr. Carlos Del Rio explains what the U.S. needs to do in order to see Covid cases dramatically drop in May.
-
CDC Says Fewer Than 6,000 Americans Have Contracted Covid After Being Fully Vaccinated
U.S. officials have confirmed fewer than 6,000 cases of Covid-19 in fully vaccinated Americans, just 0.007% of the 84 million Americans with full protection.
-
Fauci Says It's ‘Disturbing' That Some People Won't Take Covid Vaccine Because of Politics
“It’s almost paradoxical that they don’t want to get vaccinated,” White House chief medical advisor Dr. Anthony Fauci said.
-
FDA Asks Emergent Plant to Pause Manufacturing While It Investigates Botched Covid Vaccines
Emergent said the FDA initiated an inspection on April 12 and asked the company to temporarily halt manufacturing four days later.
-
Dr. Scott Gottlieb Explains Why He Believes Covid Won't Be Eradicated in U.S. Like Smallpox
Americans do not “seem to be prepared” to do what’s necessary to stamp out Covid, former FDA chief Dr. Scott Gottlieb told CNBC.
-
J&J Asked Pfizer and Moderna to Help Study Blood Clot Risks But They Declined, Report Says
J&J asked Covid vaccine rivals Pfizer and Moderna to join a study looking into the potential risk of blood clots, The Wall Street Journal reported.
-
Biden Administration Is Planning for Possible Covid Vaccine Booster Shots
The Biden administration is preparing for the potential need for Covid-19 vaccine booster shots, though nothing is certain, a top U.S. official said.
-
More Young People Are Getting Hospitalized as Covid Variants Spread. Here's What We Know
CDC Director Dr. Rochelle Walensky said earlier this month hospitals are seeing more younger adults admitted with Covid-19 as more contagious variants spread.
-
Myth Or Reality? Health Experts Weigh In on Whether ‘Herd Immunity' Is Possible
Some experts say it is achievable, though difficult — but others are warning that herd immunity may not be possible when it comes to COVID-19.
-
Merck Ends Development of Covid Drug It Acquired From OncoImmune
Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.
-
Surgeon Says Pausing J&J Vaccine for Younger Populations Makes Sense, But Could Be Lifted for Older Age Groups
Dr. Atul Gawande explains why he “thinks there is something distinct going on here” when it comes to blood clotting and J&J’s single-dose Covid-19 vaccine.
-
CDC Panel Postpones Decision on J&J Vaccine While It Investigates Rare But Serious Blood-Clot Issue
A CDC panel on Wednesday postponed a decision on J&J’s Covid vaccine while it investigates cases of six women developing a rare blood-clotting disorder.
-
Moderna Hopes to Have Covid Booster Shot for Its Vaccine Ready by the Fall, CEO Says
Moderna CEO Stephane Bancel told CNBC the biotech firm hopes to have a booster shot for its Covid vaccine to protect against variants ready by the fall.
-
Watch Live: CDC Panel Debates Use of J&J Covid Vaccine After Rare Blood Clot Issue Affects 6 Women
The Advisory Committee on Immunization Practices will review data on the women who developed a rare blood-clotting disorder.
-
White House Says U.S. Is Working to Accelerate Doses of Pfizer, Moderna Covid Vaccines
Jeff Zients said the FDA’s recommended pause on J&J’s vaccine would not have a “significant impact” on the administration’s vaccination program.
-
Dr. Anthony Fauci Explains What the U.S. Pause on J&J's Covid Vaccine Means
Dr. Fauci said the pause will give U.S. health regulators the time they need to thoroughly investigate how six women developed a rare blood clotting disorder.
-
Pausing Use of J&J Covid Vaccine Will Not Affect Timeline of Getting U.S. Vaccinated, Says Doctor
Dr. Ashish Jha explains the impact of temporarily pausing use of the J&J Covid vaccine, and why he thinks it may bolster confidence in Covid vaccines.